Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer.

Oncotarget · 2015 · PMC4537027 · PMID 25951351

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Furthermore, tumor infiltrating lymphocytes surrounding CD70 + tumor cells, showed a trend towards increasing FOXP3 expression and higher CD4/CD8 ratios.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.